Multivalent and Multispecific DR5-Binding Fusion Proteins

The disclosure relates generally to molecules that specifically engage death receptor 5 (DR5), a member of the TNF receptor superfamily (TNFRSF). More specifically the disclosure relates to multivalent and multispecific molecules that bind at least DR5.

Saved in:
Bibliographic Details
Main Authors Timmer, John C, Eckelman, Brendan P, Jones, Kyle S, Razai, Amir S, Willis, Katelyn M, Hussain, Abrahim, Deveraux, Quinn
Format Patent
LanguageEnglish
Published 03.03.2022
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The disclosure relates generally to molecules that specifically engage death receptor 5 (DR5), a member of the TNF receptor superfamily (TNFRSF). More specifically the disclosure relates to multivalent and multispecific molecules that bind at least DR5.
Bibliography:Application Number: US202117394900